| Medullary Thyroid Cancer: Clinico-pathological Profile and Outcome in a Tertiary Care Center in North India. | |
| | |
MedLine Citation:
|
PMID: 21479684 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: Recent advances in genetic screening have ushered in a new era in diagnosis and management of medullary thyroid cancer (MTC). However, the same is not true for a resource-poor country, where clinicians are still struggling to diagnose and adequately manage this relatively uncommon thyroid malignancy. We hereby present our experience of managing MTC at a tertiary care referral center in North India. METHODS: This was a retrospective study conducted between January 1990 and July 2009. Demographics, clinical profiles, details of surgical procedures, and follow-up records were reviewed. RESULTS: A total of 71 patients with MTC were identified. Mean age of this group was 39.9 ± 14.1 years, and men outnumbered women 1.7:1. Some 84.5% of patients had seemingly sporadic MTC, and 15.5% had familial MTC (MEN2a = 14.1%, MEN 2b = 1.4%). All patients had a thyroid nodule at the time of presentation. Mean tumor diameter was 4.9 cm. Cervical lymphadenopathy, mediastinal lymphadenopathy, extrathyroidal invasion, and distant metastases were present in 59%, 7.2%, 10%, and 4.2% of patients, respectively. Staging showed that 4.8% of patients were stage I, 17.5% stage II, 14.3% stage III, and 63.6% stage IV. Treatment was as follows: 92.6% of patients had total thyroidectomy (primary or secondary); 67.6% central compartment lymph node dissection, 62.3% lateral cervical lymph node dissection, and 7.2% trans-sternal mediastinal lymph node dissection performed. Some 66.7% of patients suffered from persistent hypercalcitoninemia, and 11.4% of those underwent reoperation. The 5-year and 10-year overall survival (OS) was 74.6% and 58%, respectively. CONCLUSIONS: The majority of the patients with MTC presented at stage IVa, contributing to the high rate of persistent hypercalcitoninemia. Despite a policy of observation and intervening only in overtly symptomatic patients with persistent hypercalcitoninemia, overall survival (OS) in our study was comparable to other series, reinforcing the belief that persistent hypercalcitoninemia has an indolent course in most patients. |
| | |
Authors:
|
Prateek Kumar Mehrotra; Anjali Mishra; Saroj Kanta Mishra; Gaurav Agarwal; Amit Agarwal; Ashok Kumar Verma |
Related Documents
:
|
20479894 - Optimizing the dose and duration of therapy for chronic hepatitis c. 6400034 - The clinical application of fibroblast interferon--an overview. 11583064 - Arac-based pharmacotherapy of chronic myeloid leukaemia. 21541554 - Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral c... 20828364 - Determination of biological variation of α-fetoprotein and choriogonadotropin (β chai... 20606084 - Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with ph... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-4-9 |
Journal Detail:
|
Title: World journal of surgery Volume: - ISSN: 1432-2323 ISO Abbreviation: - Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-4-11 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7704052 Medline TA: World J Surg Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Endocrine Surgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow, 226 014, India. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Optimal Period for the Prophylactic Administration of Neutrophil Elastase Inhibitor for Patients wit...
Next Document: Frequency of Ectopic and Supernumerary Intrathymic Parathyroid Glands in Patients with Renal Hyperpa...